PMCPA Case Analysis

Over 2,000 real rulings β€” analysed for what they mean to your team. Published every day.

All Cases PMCPA Case of the Week PMCPA Cases

Showing 1914 cases

2008
CASE
AUTH/2182/11/08 Stiefel Laboratories

AUTH/2182/11/08: Genus v Stiefel Laboratories (Oilatum) β€” alleged inappropriate rebate (No breach)

Genus alleged Stiefel offered a PCT a cash rebate if Oilatum was reinstated on formulary (inducement to prescribe). Accounts conflicted and evidence…

2008
CASE
AUTH/2175/10/08 ProStrakan

ProStrakan osteoporosis β€œaudit” service: inconsistent materials and unclear sponsorship wording (AUTH/2175/10/08)

Anonymous GP alleged an osteoporosis audit pushed Adcal-D3. Panel found no inducement or product-link evidence, but ruled two breaches for poor standards:…

2008
CASE
AUTH/2165/9/08 Roche Products

Roche Pulmozyme cystic fibrosis adherence scheme: Β£10 vouchers for children led to Code breaches (AUTH/2165/9/08)

Roche ran a CF adherence programme offering Β£10 high-street vouchers to children/teens for returning Pulmozyme ampoule caps. PMCPA ruled it could prompt…

2009
CASE
AUTH/2255/8/09 Stiefel

Stiefel: GP journal acne insert ruled to bring discredit on industry (Clause 2) (AUTH/2255/8/09)

A GP and pharmacist said a GP journal acne management insert was disguised promotion for Duac. After a procedural error in an…

2009
CASE
AUTH/2236/6/09 Sanofi ⭐ Case of the Week

Sanofi-Aventis dinner with oncology team ruled out of proportion (AUTH/2236/6/09)

A pharmacist alleged an oncology team dinner was purely social. PMCPA found the three-course meal with wine went beyond subsistence and was…

2009
CASE
AUTH/2209/2/09 Leo Pharma

Pfizer v Leo Pharma: Innohep β€œlong-term” promotion in cancer-associated VTE found outside the licence on appeal (AUTH/2209/2/09)

Leo promoted Innohep as β€œlong-term” therapy for VTE in cancer patients. Panel found no breach, but on appeal the Appeal Board ruled…

2008
CASE
Ferring Pharmaceuticals

Ferring voluntary admission: uncertified Pentasa conference programme ad with misleading indication and β€œexcellent efficacy” claim

Pentasa abbreviated ad in a UK conference programme was placed by Swiss global marketing without UK certification. Claims were inconsistent with SPC,…

2010
CASE
AUTH/2300/2/10 AstraZeneca

AstraZeneca: Seroquel XL BMJ ad PI not clear due to indistinct headings (AUTH/2300/2/10)

Ex-employee challenged legibility of prescribing information in BMJ ads for Seroquel XL, Zoladex and Crestor. Panel found Seroquel XL PI not clear…

2009
CASE
AUTH/2235/5/09 ProStrakan

AUTH/2235/5/09: ProStrakan’s Abstral ad implied faster onset (β€œActs in minutes”) and breached an undertaking

ProStrakan’s Abstral BMJ ad claimed β€œActs in minutes” and β€œTo hell and back in minutes”, implying onset faster than the SPC’s 15…

2008
CASE
Movetis ⭐ Case of the Week

Norgine v Movetis: β€œA new way out of chronic constipation in women” claim held misleading when unqualified inside leavepiece (Resolor)

Resolor promo used β€œAt last! A new way out of chronic constipation in women”. Appeal Board found no breach for folder/drop card…

2010
CASE
AUTH/2310/4/10 Eli Lilly

Novo Nordisk v Lilly: Diabetes UK satellite symposium and Byetta exhibition claims (AUTH/2310/4/10)

Lilly’s Diabetes UK β€œsatellite symposium” was ruled promotional, leading to pre-licence promotion findings for exenatide once-weekly (LAR) and misleading exhibition claims about…

2019
CASE
AUTH/3151/1/19 Otsuka

AUTH/3151/1/19: Anonymous employees v Otsuka Europe – SPC update confusion and incorrect Jinarc prescribing information

Otsuka Europe circulated confusing SPC implementation timelines and certified/distributed incorrect Jinarc prescribing information inconsistent with the SPC. Appeal Board ruled cumulative failings…

2019
CASE
AUTH/3176/3/19 Orion Pharma

AUTH/3176/3/19: Orion Pharma – Sponsorship declarations in email and respiratory academy website

Orion-funded respiratory education videos were promoted via an email and hosted on a sponsored academy site. No promotion found, but Orion breached…

2018
CASE
AUTH/3130/12/18 GlaxoSmithKline

AUTH/3130/12/18: Anonymous v GlaxoSmithKline – CPD meeting invite and LinkedIn post about Bexsero

GSK was not responsible for a third-party CPD invite using its logo (no breach). But a contractor’s personal LinkedIn share about Bexsero…

2019
CASE
AUTH/3274/10/19 Diurnal ⭐ Case of the Week

Diurnal: β€˜Products and Pipeline’ webpage ruled promotionalβ€”pre-licence pipeline promotion and missing PI/INN for Alkindi (AUTH/3274/10/19)

Health-professional website page combined a licensed product with pipeline products and implied they were β€œeffective, high quality”. PMCPA ruled pre-licence promotion plus…

Ask questions about any PMCPA case

Anzal, our PMCPA rulings expert, has knowledge of over 2,000 published cases β€” ask about precedents, clauses, and how they apply to your situation.

⭐ Flagship Programme

AQP Flagship Path — the complete UK ABPI signatory programme

12 modules. 12 weeks. Final Signatory readiness. The industry standard for ABPI Code signatories — £995 + VAT.

Enrol — AQP Path Learn more

📰 Weekly PMCPA Case Breakdown

One real case. One key lesson. Every week β€” free.

Subscribe Free
🎓 AQP Training